Uhlmann Price Securities LLC Makes New $1.18 Million Investment in The Clorox Company $CLX

Uhlmann Price Securities LLC acquired a new stake in shares of The Clorox Company (NYSE:CLX) during the first quarter, HoldingsChannel.com reports. The firm acquired 11,485 shares of the company’s stock, valued at approximately $1,184,000.

Other institutional investors have also modified their holdings of the company. State Street Corp raised its holdings in Clorox by 3.5% during the 3rd quarter. State Street Corp now owns 8,434,277 shares of the company’s stock valued at $1,039,946,000 after buying an additional 282,794 shares during the period. Invesco Ltd. lifted its position in Clorox by 22.1% in the fourth quarter. Invesco Ltd. now owns 4,880,341 shares of the company’s stock worth $492,085,000 after buying an additional 884,751 shares during the last quarter. Geode Capital Management LLC boosted its stake in Clorox by 0.3% during the fourth quarter. Geode Capital Management LLC now owns 3,172,233 shares of the company’s stock worth $318,613,000 after buying an additional 10,060 shares during the period. Van ECK Associates Corp boosted its stake in Clorox by 15.7% during the fourth quarter. Van ECK Associates Corp now owns 3,136,405 shares of the company’s stock worth $316,244,000 after buying an additional 426,433 shares during the period. Finally, Two Sigma Investments LP increased its position in Clorox by 33.8% during the third quarter. Two Sigma Investments LP now owns 1,740,175 shares of the company’s stock valued at $214,564,000 after acquiring an additional 439,797 shares during the last quarter. 78.53% of the stock is owned by institutional investors.

Clorox Trading Up 0.1%

CLX stock opened at $95.90 on Friday. The Clorox Company has a 12 month low of $84.70 and a 12 month high of $132.03. The firm’s 50-day moving average is $95.71 and its 200 day moving average is $104.82. The company has a market capitalization of $11.60 billion, a PE ratio of 15.57, a P/E/G ratio of 0.50 and a beta of 0.56. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65.

Clorox (NYSE:CLX) last released its quarterly earnings data on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.55 by $0.09. The company had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.67 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The firm’s quarterly revenue was up .1% on a year-over-year basis. During the same period in the previous year, the company earned $1.45 EPS. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, research analysts anticipate that The Clorox Company will post 5.61 EPS for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on CLX shares. Wells Fargo & Company reduced their target price on shares of Clorox from $100.00 to $95.00 and set an “equal weight” rating on the stock in a research note on Monday, May 18th. The Goldman Sachs Group reaffirmed a “sell” rating and set a $83.00 price target on shares of Clorox in a research note on Friday, May 1st. TD Cowen increased their price objective on shares of Clorox from $98.00 to $111.00 and gave the stock a “hold” rating in a research report on Tuesday, March 31st. Evercore reissued an “underperform” rating and issued a $110.00 price objective on shares of Clorox in a research note on Friday, May 1st. Finally, Morgan Stanley dropped their target price on Clorox from $110.00 to $97.00 and set an “equal weight” rating for the company in a research report on Friday, May 1st. One analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and five have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Reduce” and a consensus price target of $103.40.

Insider Activity

In other news, Director Pierre R. Breber purchased 5,000 shares of the stock in a transaction that occurred on Tuesday, May 5th. The stock was purchased at an average price of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the acquisition, the director owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. This trade represents a 38.46% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 0.63% of the company’s stock.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.